Peripheral serotonin reduction, in turn, impedes the activity of the vagus nerve and impairs hippocampal responses and memory. These findings provide a possible explanation for neurocognitive symptoms associated with viral persistence in Long COVID.

Since SARS-CoV-2 BA.5 (Omicron) emerged and spread in 2022, Omicron lineages have markedly diversified.

In the last three years, extensive research has demonstrated the safety and efficacy of COVID-19 vaccines. These vaccines have played a critical role in reducing mortality and hospitalization rates.

On 11 October 2023, for the fourth edition of EU Flu Day, around 100 people gathered in person and online to participate in the event at the European Parliament

Current vaccines should be tailored to combat future SARS-CoV-2 variants.

The COVID-19 pandemic and society’s response to it may have constrained the ability of those with diabetes to achieve a healthy lifestyle.

Steering Group on Influenza Vaccination releases on the EU Flu Day a set of Policy Recommendations for the EU and national governments to expand influenza vaccine uptake.

An overview of vaccination recommendations for 2021-22 and coverage rates for the 2018–19 to 2020–21 influenza seasons.

Last year’s autumn and winter seasons were unpredictable. Last winter, the cumulative impacts of influenza, COVID-19, and respiratory syncytial virus or RSV hit the very young and the very old the hardest.

ESWI 2023: 10 key take home messages

Research led by Dr Carolien van de Sandt, a senior research fellow at the Doherty Institute and 2023 Claude Hannoun Prize, and UNSW Sydney shows that cells are replaced as we get older by ones less able to read threat from infections

Oral Antiviral (OAV) COVID-19 treatments are widely used, but evidence for their effectiveness against the Omicron variant in higher risk, vaccinated individuals is limited.